DIVISLABPharmaceuticals

Divis Laboratories LtdQuarterly Results & Earnings

5947.00
-1.42%
Profit Growth YoY35.10%Latest quarter
Sales Growth YoY16.12%Latest quarter
Sales CAGR 5Y11.65%5 year compound
Profit CAGR 5Y10.41%5 year compound
📋

Quarterly Performance

YoY Profit Growth+35.10%
🔥 Exceptional growth
YoY Sales Growth+16.12%
✅ Strong growth
OPM 5Y Average
Operating profit margin
34.98%
EPS Growth 5Y
10.41%
Interest Coverage
Higher = safer debt servicing
270.58
ROE
15.35%
ROCE
20.44%
💡

Growth Analysis

Divis Laboratories Ltd reported YoY profit growth of 35.10% and revenue growth of 16.12% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 11.65% and profits at 10.41% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.